PhilHealth Expands Access to Tb Medicines Through Gamot Starting November 1

What Readers Should Know
PhilHealth will expand access to selected first-line TB medicines through accredited GAMOT facilities starting November 1, 2026. Eligible patients with confirmed drug-susceptible tuberculosis can obtain covered prescriptions without reducing their ₱20,000 annual GAMOT benefit.
Key Takeaways
- Expanded access begins on November 1, 2026.
- The policy covers eligible members and dependents with confirmed drug-susceptible tuberculosis.
- Covered medicines require prescriptions issued through the GAMOT application.
- Anti-TB medicines under the policy will not reduce the ₱20,000 annual GAMOT allocation.
- Each transaction allows up to one month’s supply, with full dispensing required within two days of prescription issuance.
Eligible patients with confirmed drug-susceptible tuberculosis can obtain covered medicines without using their ₱20,000 annual GAMOT allocation.
PhilHealth will expand access to selected first-line tuberculosis medicines through its Guaranteed and Accessible Medications for Outpatient Treatment (GAMOT) program starting November 1, 2026, giving eligible members and dependents another way to obtain prescribed treatment.
Under PhilHealth Circular No. 2026-0018, patients with confirmed drug-susceptible tuberculosis (DS-TB) may access covered medicines at accredited GAMOT facilities through prescriptions issued by authorized physicians using the GAMOT application.
The expansion aims to help patients begin treatment and avoid interruptions by connecting primary care consultations with another accredited source of medication.
Preserving the annual medicine benefit
Covered first-line anti-TB medicines dispensed through this arrangement will not reduce a member’s ₱20,000 annual GAMOT benefit limit. This preserves the allocation for other covered outpatient medicines.
Physicians may prescribe up to one month’s supply per transaction. Accredited GAMOT facilities must dispense the full prescribed quantity within two days of prescription issuance.
Prescribing and dispensing must follow Department of Health–National TB Control Program standards.
Supporting continuity of care
The additional medicine access point forms part of PhilHealth’s efforts to strengthen primary care through its Yaman ng Kalusugan Program (YAKAP).
For eligible patients and their families, the key change is a new route to prescribed TB medication while keeping their annual GAMOT allocation available for other covered needs.
Patients should coordinate with their YAKAP physician about eligibility, prescriptions, and participating GAMOT facilities. Further information is available through PhilHealth’s official website.
Frequently Asked Questions
When will expanded access begin?
November 1, 2026.
Who can access the covered TB medicines?
Eligible PhilHealth members and dependents with confirmed drug-susceptible tuberculosis, subject to program requirements.
Where can patients obtain the medicines?
At PhilHealth-accredited GAMOT facilities, using a prescription issued by an authorized physician through the GAMOT application.
Will TB medicines reduce the annual GAMOT benefit?
No. Covered first-line anti-TB medicines under this policy will not be deducted from the ₱20,000 annual limit.
How much medicine can be prescribed per transaction?
Up to one month’s supply. The facility must dispense the complete prescribed quantity within two days of prescription issuance.